Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LAMIVUDINE vs LANSOPRAZOLE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LAMIVUDINE vs LANSOPRAZOLE: Safety Overview

Metric LAMIVUDINE LANSOPRAZOLE
Total FAERS Reports 16,685 60,931
Deaths Reported 1,838 6,896
Death Rate 11.0% 11.3%
Hospitalizations 3,442 12,277
Average Patient Age 43.0 yrs 60.3 yrs
% Female Patients 35.2% 57.3%
FDA Approval Date Apr 19, 2018 Apr 23, 2010
Manufacturer Aurobindo Pharma Limited Ascend Laboratories, LLC
Route ORAL ORAL
Marketing Status Prescription Discontinued